Cerus Corporation - Common Stock (NQ:CERS)

2.245 -0.115 (-4.87%)

Delayed Quote Updated: 12:06 PM EST, Nov 3, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Cerus Corporation - Common Stock

< Previous 1 2 3 4 Next >

Cerus Corporation Announces Third Quarter 2026 Financial Results

November 02, 2026

From Cerus Corporation

Via Business Wire

Cerus Corporation Announces Positive Topline Results from Phase 3 RedeS Trial of the INTERCEPT Blood System for Red Blood Cells

November 02, 2026

From Cerus Corporation

Via Business Wire

Cerus Corporation to Release Third Quarter 2026 Financial Results on November 2, 2026

October 19, 2026

From Cerus Corporation

Via Business Wire

Cerus Corporation Announces Workshop and Abstracts at the 2026 AABB Annual Meeting

October 14, 2026

From Cerus Corporation

Via Business Wire

Cerus Corporation Announces Second Quarter 2026 Financial Results

July 30, 2026

From Cerus Corporation

Via Business Wire

Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026

July 16, 2026

From Cerus Corporation

Via Business Wire

Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress

June 17, 2026

From Cerus Corporation

Via Business Wire

Cerus Corporation Closes New Debt Facility of Up to $110 Million

June 08, 2026

From Cerus Corporation

Via Business Wire

Cerus Corporation Announces First Quarter 2026 Financial Results

April 30, 2026

From Cerus Corporation

Via Business Wire

Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System

April 27, 2026

From Cerus Corporation

Via Business Wire

Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026

April 16, 2026

From Cerus Corporation

Via Business Wire

Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer

March 16, 2026

From Cerus Corporation

Via Business Wire

Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results

March 02, 2026

From Cerus Corporation

Via Business Wire

Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference

February 20, 2026

From Cerus Corporation

Via Business Wire

Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026

February 17, 2026

From Cerus Corporation

Via Business Wire

DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus’ INTERCEPT™ Blood System in Routine Clinical Practice

January 22, 2026

From Cerus Corporation

Via Business Wire

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook

January 11, 2026

From Cerus Corporation

Via Business Wire

Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America

December 10, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance

November 06, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting

October 21, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025

October 16, 2025

From Cerus Corporation

Via Business Wire

The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions

August 25, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025

August 21, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation Announces Second Quarter 2025 Financial Results

August 05, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025

July 22, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury

July 21, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update

July 02, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation Celebrates World Blood Donor Day 2025

June 13, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

June 03, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan

May 29, 2025

From Cerus Corporation

Via Business Wire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.